Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride reduces hair growth and is safe for women with excessive hair.

Hirsutism in females is caused by high male hormones or sensitive hair follicles.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Men might have a version of the female disease, polycystic ovarian syndrome, shown by changes in hormone levels and early baldness, but more research is needed to fully understand it.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

Finasteride effectively reduces DHT and E2 levels, helping with prostate enlargement.

Suppressing certain hormones might help prevent prostate cancer.

Progestogens are essential in menopausal hormone therapy to prevent uterine cancer and must be chosen carefully based on individual needs.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

17α-estradiol boosts aromatase activity in female hair follicles, potentially helping with hair loss.

A 15-year-old girl with rare reproductive disorders received hormone therapy to develop secondary sexual traits, but infertility persisted.

Testosterone makes the connections in the uterus lining simpler and lowers certain protein levels, which might lead to infertility.

Most transgender adolescents continued hormone treatment, with few stopping due to reasons other than returning to their birth gender.

Skin creams that block male hormones may help with hair growth, hair loss, and acne.

Spironolactone and finasteride are equally effective for hirsutism in transgender women.

Estrogens can slow skin aging after menopause, but can't restore youthful skin.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Testosterone makes XX skin more like male skin by changing its structure and cell makeup.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Androgens reduce BMP2, which weakens the ability of certain cells to help hair stem cells become different types of cells.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Testosterone significantly affects urination differences between male and female mice.

Hormonal treatments, including birth control and antiandrogens, can effectively treat acne in women.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.

Enzyme activities do not cause early pubic hair in these girls.

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.